If America creates most of the innovative drug therapies in the world, why can’t America consumers catch a break when it comes to the pricing of these drugs? It’s a questions that has alluded policymakers in this country for years. And to blame it on any one thing–advertising, cost of research or the insurance companies poking in for a piece of the pie–is too simplistic. So we walk you through the process of a drug coming to market, patent protections and the like, all the way through to marketing and distribution, to help unpack the mystery of high drug prices and what we can do about it. Our guest is James Capretta, a co-author of the American Enterprise Institute’s fine report on the issue.